SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kershaw, E. E. andFlier, J. S. ( 2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 25482556.
  • 2
    Ouchi, N.,Parker, J. L.,Lugus, J. J., andWalsh, K. ( 2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2, 8597.
  • 3
    Raghu, P. andSivakumar, B. ( 2004) Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochim. Biophys. Acta 1703, 19.
  • 4
    D'Ambrosio, D. N.,Clugston, R. D., andBlaner, W. S. ( 2011) Vitamin A metabolism: an update. Nutrients 3, 63103.
  • 5
    Yang, Q.,Graham, T. E.,Mody, N.,Preitner, F.,Peroni, O. D., et al. ( 2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356362.
  • 6
    Blaner, W. S. ( 2007) STRA6, a cell-surface receptor for retinol-binding protein: the plot thickens. Cell Metab. 5, 164166.
  • 7
    Shepherd, P. R. andKahn, B. B. ( 1999) Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341, 248257.
  • 8
    Abel, E. D.,Peroni, O.,Kim, J. K.,Kim, Y. B., andBoss, O. ( 2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729733.
  • 9
    Zisman, A.,Peroni, O. D.,Abel, E. D.,Michael, M. D.,Mauvais-Jarvis, F., et al. ( 2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6, 924928.
  • 10
    Manolescu, D. C.,Sima, A., andBhat, P. V. ( 2010) All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J. Nutr. 140, 311316.
  • 11
    Kotnik, P.,Fischer-Posovszky, P., andWabitsch, M. ( 2011) RBP4: a controversial adipokine. Eur. J. Endocrinol. 165, 703711.
  • 12
    Tan, Y.,Sun, L. Q.,Kamal, M. A.,Wang, X.,Seale, J. P., et al. ( 2011) Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. Biochim. Biophys. Acta 1811, 10451053.
  • 13
    Berry, D. C. andNoy, N. ( 2012) Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochim. Biophys. Acta 1821, 168176.
  • 14
    Graham, T. E.,Yang, Q.,Blüher, M.,Hammarstedt, A.,Ciaraldi, T. P., et al. ( 2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354, 25522563.
  • 15
    Cho, Y. M.,Youn, B. S.,Lee, H.,Lee, N.,Min, S. S., et al. ( 2006) Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29, 24572461.
  • 16
    Kloting, N.,Graham, T. E.,Berndt, J.,Kralisch, S., andKovacs, P. ( 2007) Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab. 6, 7987.
  • 17
    Gavi, S.,Stuart, L. M.,Kelly, P.,Melendez, M. M.,Mynarcik, D. C., et al. ( 2007) Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J. Clin. Endocrinol. Metab. 92, 18861890.
  • 18
    Aeberli, I.,Biebinger, R.,Lehmann, R.,L'Allemand, D.,Spinas, G. A., et al. ( 2007) Serum retinol-binding protein 4 concentrations and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J. Clin. Endocrinol. Metab. 92, 43594365.
  • 19
    Qi, Q.,Yu, Z.,Ye, X.,Zhao, F.,Haung, P., et al. ( 2007) Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J. Clin. Endocrinol. Metab. 92, 48274834.
  • 20
    Krzyzanowska, K.,Zemany, L.,Krugluger, W.,Schernthaner, G. H.,Mittermayer, F., et al. ( 2008) Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 51, 11151122.
  • 21
    Haider, D. G.,Schindler, K.,Prager, G.,Bohdjalian, A.,Luger, A., et al. ( 2007) Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J. Clin. Endocrinol. Metab. 92, 11681171.
  • 22
    Balagopal, P.,Graham, T. E.,Kahn, B. B.,Altomare, A., andFunanage, V. ( 2007) Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J. Clin. Endocrinol. Metab. 92, 19711974.
  • 23
    Lim, S.,Choi, S. H.,Jeong, I. K.,Kim, J. H.,Moon, M. K., et al. ( 2008) Insulin-sensitizing effects of exercise on adiponectin and retinol binding protein-4 concentrations in young and middle aged women. J. Clin. Endocrinol. Metab. 93, 22632268.
  • 24
    Krempf, M.,Ranganathan, S.,Ritz, P.,Morin, M., andCharbonnel, B. ( 1991) Plasma vitamin A and E in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) adult diabetic patients. Int. J. Vitam. Nutr. Res. 61, 3842.
  • 25
    Takitani, K.,Miyazaki, H.,Takaya, R., andTamai, H. ( 2008) Expression of β-carotene 15,15′-monooxygenase gene and retinol status in type 2 diabetic Goto-Kakizaki rats. Biofactors 33, 7783.
  • 26
    Erikstrup, C.,Mortensen, O. H.,Nielsen, A. R.,Fischer, C. P.,Plomgaard, P., et al. ( 2009) RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes. Metab. 11, 204212.
  • 27
    Nair, A. K.,Sugunan, D.,Kumar, H., andAnilkumar, G. ( 2010) Case–control analysis of SNPs in GLUT4, RBP4 and STRA6: association of SNPs in STRA6 with type 2 diabetes in a South Indian population. PLoS One 5, e11444.
  • 28
    Mody, N.,Graham, T. E.,Tsuji, Y.,Yang, Q., andKahn, B. B. ( 2008) Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 294, E785E793.
  • 29
    Refai, E.,Dekki, N.,Yang, S. N.,Imreh, G.,Cabrera, O., et al. ( 2005) Transthyretin constitutes a functional component in pancreatic β-cell stimulus-secretion coupling. Proc. Natl. Acad. Sci. USA 102, 1702017025.
  • 30
    Westermark, G. T. andWestermark, P. ( 2008) Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes. Exp. Diabetes Res. 2008, 429274.
  • 31
    Cras-Meneur, C.,Inoue, H.,Zhou, Y.,Ohsugi, M.,Bernal-Mizrachi, E., et al. ( 2004) An expression profile of human pancreatic islet mRNAs by serial analysis of gene expression (SAGE). Diabetologia 47, 284299.
  • 32
    Itoh, N.,Hanafusa, T.,Miyagawa, J.,Tamura, S.,Inada, M., et al. ( 1992) Transthyretin (pre-albumin) in the pancreas and sera of newly diagnosed type I (insulin-dependent) diabetic patients. J. Clin. Endocrinol. Metab. 74, 13721377.
  • 33
    Rosmond, R.,Dallman, M. F., andBjorntorp, P. ( 1998) Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83, 18531859.
  • 34
    Martinho, A.,Goncalves, I.,Costa, M., andSantos, C. R. ( 2012) Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors. J. Mol. Neurosci. 48, 113.
  • 35
    Fliser, D.,Pacini, G.,Engelleiter, R.,Kautzky-Willer, A.,Prager, R., et al. ( 1998) Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 53, 13431347.
  • 36
    Mosenthal, H. O. andLoughlin, W. C. ( 1944) Vitamin A, B and C in diabetic children. Arch. Intern. Med. 73, 391396.
  • 37
    Martinoli, L.,Di Felice, M.,Seghieri, G.,Ciuti, M.,De Giorgio, L. A., et al. ( 1993) Plasma retinol and α-tocopherol concentrations in insulin-dependent diabetes mellitus: their relationship to microvascular complications. Int. J. Vitam. Nutr. Res. 63, 8792.
  • 38
    Baena, R. M.,Campoy, C.,Bayes, R.,Blanca, E.,Fernandez, J. M., et al. ( 2002) Vitamin A, retinol binding protein and lipids in type 1 diabetes mellitus. Eur. J. Clin. Nutr. 56, 4450.
  • 39
    Krill, D.,O'Leary, L.,Koehler, A. N.,Kramer, M. K.,Warty, V., et al. ( 1997) Association of retinol binding protein in multiple-case families with insulin-dependent diabetes. Hum. Biol. 69, 8996.
  • 40
    Basu, T. K.,Tze, W. J., andLeichter, J. ( 1989) Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am. J. Clin. Nutr. 50, 329331.
  • 41
    Basu, T. K. andBasualdo, C. ( 1997) Vitamin A homeostasis and diabetes mellitus. Nutrition 13, 804806.
  • 42
    Wako, Y.,Suzuki, K.,Goto, Y., andKimura, S. ( 1986) Vitamin A transport in plasma of diabetic patients. Tohoku J. Exp. Med. 149, 133143.
  • 43
    Granado, F.,Olmedilla, B.,Gil-Martínez, E.,Blanco I.,Millan I., et al. ( 1998) Carotenoids, retinol and tocopherols in patients with insulin-dependent diabetes mellitus and their immediate relatives. Clin. Sci. (Lond) 94, 189195.
  • 44
    Morinobu, T. andTamai, H. ( 2000) β-Carotene 15,15′-dioxygenase activity in streptozotocin-induced diabetic rats. J. Nutr. Sci. Vitaminol. (Tokyo) 46, 263265.
  • 45
    Dubrey, S. W.,Beetham, R.,Miles, J.,Noble, M. I.,Rowe, R., et al. ( 1997) Increased urinary albumin and retinol-binding protein in type I diabetes. A study of identical twins. Diabetes Care 20, 8489.
  • 46
    Pontuch, P.,Jensen, T.,Deckert, T.,Ondrejka, P., andMikulecky, M. ( 1992) Urinary excretion of retinol-binding protein in type 1 (insulin-dependent) diabetic patients with microalbuminuria and clinical diabetic nephropathy. Acta Diabetol. 28, 206210.
  • 47
    Basu, T. K.,Leichter, J., andMcNeill, J. H. ( 1990) Plasma and liver vitamin A concentrations in streptozotocin diabetic rats. Nutr. Res. 10, 421427.
  • 48
    Lu, J.,Dixon, W. T.,Tsin, A. T., andBasu, T. K. ( 2000) The metabolic availability of vitamin A is decreased at the onset of diabetes in BB rats. J. Nutr. 130, 19581962.
  • 49
    Tuitoek, P. J.,Lakey, J.,Rajotte, R. V.,Tsin, A. T. C., andBasu, T. K. ( 1996) Effect of insulin treatment or zinc supplementation on vitamin A status in streptozotocin-induced diabetic rats. J. Clin. Biochem. Nutr. 19, 165169.
  • 50
    Tuitoek, P. J.,Thomson, A. B.,Rajotte, R. V., andBasu, T. K. ( 1994) Intestinal absorption of vitamin A in streptozotocin-induced diabetic rats. Diabetes Res. 25, 151158.
  • 51
    Chen, M.,Thomson, A. B.,Tsin, A. T., andBasu T. K. ( 2003) The hepatic retinyl ester hydrolase activity is depressed at the onset of diabetes in BB rats. Br. J. Nutr. 89, 231238.
  • 52
    Stadler, M.,Storka, A.,Theuer, E. A.,Krebs, M.,Vojtassakova, E., et al. ( 2010) Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations. Clin. Endocrinol. (Oxf). 72, 763769.
  • 53
    Chertow, B. S.,Blaner, W. S.,Baranetsky, N. G.,Sivitz, W. I.,Cordle, M. B., et al. ( 1987) Effects of vitamin A deficiency and repletion on rat insulin secretion in vivo and in vitro from isolated islets. J. Clin. Invest. 79, 163169.
  • 54
    Chertow, B. S.,Driscoll, H. K.,Blaner, W. S.,Meda, P.,Cordle, M. B., et al. ( 1994) Effects of vitamin A deficiency and repletion on rat glucagon secretion. Pancreas 9, 475484.
  • 55
    Chiefari, E.,Paonessa, F.,Iiritano, S.,Le Pera, I.,Palmieri, D., et al. ( 2009) The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol. 7, 24.
  • 56
    Dinneen, S.,Alzaid, A.,Turk, D., andRizza, R. ( 1995) Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38, 337343.
  • 57
    Shah, P.,Basu, A.,Basu, R., andRizza, R. ( 1999) Impact of lack of suppression of glucagon on glucose tolerance in humans. Am. J. Physiol. 277, E283E290.
  • 57
    Jourdan, M.,Jaleel, A.,Karakelides, H.,Ford, G.C.,Kahn, B.B. et al. ( 2009) Impact of type 1 diabetes and insulin treatment on plasma levels and fractional synthesis rate of retinol-binding protein 4. J. Clin. Endocrinol. Metab. 94, 51255130.
  • 59
    Fishel, M. A.,Watson, G. S.,Montine, T. J.,Wang, Q.,Green, P. S., et al. ( 2005) Hyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adults. Arch. Neurol. 62, 15391544.